MARÍA ÁNGELES
MORO SÁNCHEZ
Catedrática de universidad
Fundación Hospital Alcorcón
Alcorcón, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (5)
2007
-
The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats
Pediatric Research, Vol. 62, Núm. 3, pp. 255-260
2006
-
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats
Pediatric Research, Vol. 60, Núm. 2, pp. 169-173
-
Nitric oxide synthase as a target for the prevention of hypoxic-ischemic newborn brain damage
Current Enzyme Inhibition, Vol. 2, Núm. 3, pp. 219-229
2005
-
Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy
Journal of Neuroscience Methods, Vol. 145, Núm. 1-2, pp. 205-212
-
Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia
Biology of the Neonate, Vol. 88, Núm. 4, pp. 291-298